The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Scott A ReadMark W Douglas

Abstract

Patients who respond poorly to therapies for hepatitis C virus (HCV) infection display a characteristic phenotype with high basal hepatic interferon-stimulated gene (ISG) expression, but limited induction following interferon (IFN) treatment. The molecular pathways that mediate this refractory state are not known. We examined whether the AMPK activator metformin, the PPARγ agonist pioglitazone, or the PPARα agonist WY-14643 could potentiate IFN responses, reverse IFN refractoriness, and enhance viral eradication in hepatocytes. WY-14643 demonstrated the strongest antiviral synergy with IFN-α and so was tested in the context of chronic IFN activation. Cells rendered refractory to IFN by IFN-α pretreatment were resensitized by WY-14643, as demonstrated by improved STAT1 phosphorylation, promoter activation, and ISG expression. WY-14643 treatment reduced the expression of key negative regulators of IFN signaling: the AXL receptor tyrosine kinase, suppressor of cytokine signaling (SOCS) 1 and 3, which are upregulated in the IFN-refractory state. AXL is a novel regulator of IFN-α signaling that is induced by HCV infection in vitro and which may drive SOCS3 expression. Our data suggests that PPARα agonists could be a useful adjunct t...Continue Reading

References

Jun 5, 2002·Genome Research·W James KentDavid Haussler
Dec 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Calogero CammàAntonio Craxì
Apr 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jean-Philippe HerbeuvalGene M Shearer
Aug 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert E LanfordKathleen M Brasky
Aug 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marcello PersicoAchille Iolascon
Aug 9, 2007·Cytokine & Growth Factor Reviews·Nancy C Reich
May 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Magdalena Sarasin-FilipowiczMarkus H Heim
Jan 7, 2009·PPAR Research·Liliane Michalik, Walter Wahli
Jul 1, 2009·Molecular and Cellular Biology·Magdalena Sarasin-FilipowiczMarkus H Heim
Jan 30, 2010·Nucleic Acids Research·David L M van der MeerSander Kersten
May 28, 2010·The Journal of General Virology·Daniel M JonesJohn McLauchlan
Apr 1, 2011·The New England Journal of Medicine·Fred PoordadUNKNOWN SPRINT-2 Investigators
Apr 13, 2013·Science·Pamela M Odorizzi, E John Wherry
Jan 9, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrew HillNathan Ford

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
protein assay
electrophoresis
ChIP
histone acetylation
immunoprecipitation

Software Mentioned

Image J
UCSC genome browser

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.